Recalls / Active ingredient / Neomycin Sulfate
Neomycin Sulfate
6 FDA drug recalls involving the active ingredient “Neomycin Sulfate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-04-24 | Class II | Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc/ Neomycin Sulfate/ Polymyxin B Sulfate, Net Wt | KENIL HEALTHCARE PRIVATE LIMITED |
| 2022-08-23 | Class II | Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, I | Teva Pharmaceuticals USA Inc |
| 2022-04-13 | Class II | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC | Mckesson Medical-Surgical Inc. Corporate Office |
| 2021-03-15 | Class II | NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., | Cardinal Health Inc. |
| 2019-10-17 | Class III | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx Only, Sterile, 5 mL bottle, Manu | Sandoz Inc |
| 2013-11-22 | Class II | Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163 | Faria Limited LLC dba Sheffield Pharmaceuticals |